Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be hel-Reference-Cited by-同舟云学术

Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be hel

Published:2015-08-06 Issue:9 Volume:69 Page:978-997
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Citrome L.¹

Affiliation:

1. New York Medical College; Valhalla NY USA

Publisher

Hindawi Limited

Subject

General Medicine

Reference50 articles.

1. Otsuka REXULTI (brexpiprazole) tablets, for oral use 2015 http://www.otsuka-us.com/products/Documents/Rexulti.PI.pdf

2. Otsuka, Lundbeck U.S. FDA Approves Otsuka and Lundbeck's REXULTI (Brexpiprazole) as adjunctive treatment for adults with major depressive disorder and as a treatment for adults with Schizophrenia 2015 http://www.otsuka-us.com/newsroom/Pages/NewsArticle.aspx?ItemId=13

3. Brexpiprazole: a new dopamine D2 receptor partial agonist for the treatment of schizophrenia and major depressive disorder;Citrome;Drugs Today (Barc),2015

4. Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making;Volavka;Expert Opin Pharmacother,2009

5. Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed;Citrome;Postgrad Med,2010

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel and facile process for the preparation of Brexpiprazole an antipsychotic drug;Chemical Papers;2024-01-18

2. Brexpiprazole versus placebo or other antidepressive agents for treating depression;Cochrane Database of Systematic Reviews;2023-07-28

3. Structure-based discovery of an antipsychotic drug, paliperidone, as a modulator of human superoxide dismutase 1: a potential therapeutic target in amyotrophic lateral sclerosis;Acta Crystallographica Section D Structural Biology;2023-05-19

4. G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders;Signal Transduction and Targeted Therapy;2023-05-03

5. Lumateperone for the Treatment of Schizophrenia;The Journal of Clinical Psychiatry;2023-03-06